RECRUITING

Long-Covid-19 Alleviation Through Learning Mindfulness Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here the investigators are studying whether a mindfulness intervention can help reduce stress, reduce Long COVID symptoms, and improve quality of life among people living with Long COVID. The mindfulness intervention is a series of recorded mindfulness sessions, which were created by the study team. People who decide to take part will be randomly assigned to receive the study mindfulness intervention immediately after joining the study or to receive the study mindfulness intervention 8 weeks after joining the study. All participants will continue their usual medical care. Participants will complete online surveys to measure symptoms over time. The study will last 6 months.

Official Title

Long-Covid-19 Alleviation Through Learning Mindfulness Study (LONG-CALM)

Quick Facts

Study Start:2024-05-21
Study Completion:2027-11-21
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07140094

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age \> or = 18
  2. * Willing and able to provide informed consent
  3. * Access to the internet
  4. * Self-reported history of SARS-CoV-2 infection
  5. * Current symptoms attributed to PASC by participant or by participant's medical provider; ongoing symptoms that persisted \>= 12 weeks after Covid-19 illness
  1. * Participating in another clinical trial of an intervention for PASC symptoms
  2. * Engaged in a structured MBI

Contacts and Locations

Study Contact

Deborah Theodore, MD
CONTACT
2123058739
dat2132@cumc.columbia.edu

Principal Investigator

Deborah Theodore, MD
PRINCIPAL_INVESTIGATOR
Columbia University

Study Locations (Sites)

Columbia University
New York, New York, 10032
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Deborah Theodore, MD, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-21
Study Completion Date2027-11-21

Study Record Updates

Study Start Date2024-05-21
Study Completion Date2027-11-21

Terms related to this study

Keywords Provided by Researchers

  • Covid

Additional Relevant MeSH Terms

  • Long COVID
  • Long Covid19
  • Post-Acute COVID-19
  • Post-Acute COVID-19 Syndrome
  • Post-Acute COVID-19 Infection
  • COVID Long-Haul